CBT

$67.82-0.77 (-1.12%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Cabot Corporation operates as a specialty chemicals and performance materials company.

Recent News

Zacks
Mar 18, 2026

Do Options Traders Know Something About Cabot Stock We Don't?

Investors need to pay close attention to CBT stock based on the movements in the options market lately.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 12, 2026

Is Cabot (CBT) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether Cabot's current share price reflects its true worth, this article will walk you through how that value stacks up against a few simple checks. The stock last closed at US$67.76, with returns of 9.5% decline over 7 days, 9.2% decline over 30 days, 1.1% year to date, 14.4% decline over 1 year, 0.6% decline over 3 years, and 39.4% over 5 years. Recent market moves around Cabot have come against a backdrop of ongoing investor interest in materials names and how they...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 9, 2026

Storm Fallout and Segment Reset: What's Next for Innospec Stock?

IOSP faces a storm-hit start to 2026 with weaker H1 earnings with recovery now hinges on a second-half rebound in Performance Chemicals and Oilfield Services.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 9, 2026

What's Driving Innospec Stock in FY26 After the Winter Storm

IOSP faces a storm-hit start to 2026 as lost Performance Chemicals volumes delay recovery, leaving Fuel Specialties to steady results until a second-half rebound.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 9, 2026

DRAs and Middle East Mix Shift Shape IOSP's FY26 Strategy

Innospec heads into 2026 with storm-hit first half, betting on DRA ramp, Middle East oilfield growth and second-half margin recovery.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.